This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Boost Your Health and Skin with Collagen During Menopause As we navigate the natural changes of menopause, supporting our body becomes more essential than ever. Collagen, a protein our bodies produce less of over time, plays a critical role in skin elasticity, joint health, and bone density. In fact, collagen supplements can be a powerful addition to your wellness routine, especially for women in their 40s and beyond.
Their trends team has been analyzing the wellness space and upcoming trends for more than 20 years. Here are the trends that GWS noticed took priority in 2024, and will revolutionize wellness for 2025 and beyond.
Chillicothe, Missouri – U.S. Dermatology Partners physician, Dr. Megan Lent , is named Best Dermatologist in the Chillicothe Constitution-Tribune’s Reader’s Choice Awards 2024! U.S. Dermatology Partners is Recognized in the Chillicothe Constitution-Tribune’s 2024 Reader’s Choice Awards U.S. Dermatology Partners is thrilled to congratulate Dr.
As National Eczema Awareness Month 2024 draws to a close, TDD/JDNPPA sat down with Kristin Belleson, the new President and CEO of the National Eczema Association (NEA), to discuss the group’s upcoming education and advocacy initiatives, learn how healthcare providers can be more involved with the NEA, and get some intel on the coveted NEA Seal of Acceptance program.
As a practitioner in the field of medical aesthetics, staying ahead of trends is crucial for delivering the best outcomes for our patients. One of the most significant shifts we’re witnessing is the rise of biostimulatory injectables. These innovative treatments not only enhance our toolkit but also redefine how we approach skin rejuvenation, focusing on long-term skin health alongside immediate results.
Deuruxolitinib (Leqselvi, Sun Pharma) shows ongoing and clinically meaningful improvements for up to 68 weeks in scalp hair regrowth among alopecia areata patients, according to pooled long-term results from open-label extension presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV. The U.S. Food and Drug Administration approved deuruxolitinib (8mg) tablets for the treatment of adults with severe AA earlier this year.
Shahriari highlighted advanced dermatology treatments, clinical trial inclusivity, and key care strategies for complex skin conditions at Fall Clinical 2024.
Sherrif F. Ibrahim, MD, PhD, an Assistant Professor in the Department of Dermatology at the University of Rochester Medical Center in Rochester, NY, shares his enthusiasm for Sciton’s BBL HEROic , a workhorse broadband light device that he uses to address pigmentation, vascularity, and skin quality on the face, chest, and arms. The post Devices Dermatologists Love Episode Three: Sciton’s BBL HEROic With Dr.
This review of the latest dermatologic studies includes discussions on the development of the Hand Eczema Impact Scale, the role of tofacitinib on Th1 and Th2 cytokines, and more.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
102 
Let's personalize your content